(0123–0149) Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Poster abstract session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Autoinflammatory Diseases Associated with NOD2 and Other Concurrent Genetic Mutations
  

  Abstract Poster Presenter: Hafsa Nomani, DO – Stony Brook University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Increase of Serum Endothelin-1 Levels in Patients with Interstitial Lung Disease Associated with Autoimmune Diseases
  

  Abstract Poster Presenter: Sara Remuzgo-Martinez, PhD – Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic bone Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecillla
• 1:00 PM – 3:00 PM Eastern Time

  Evaluation of Comorbidity Burden and Its Effect on Lung Disease Progression and Mortality in a Cohort of Patients with Interstitial Pneumonia with Autoimmune Features
  

  Abstract Poster Presenter: Elena Joerns, MD – UT Southwestern
• 1:00 PM – 3:00 PM Eastern Time

  Baseline Characteristics in Patients with Eosinophilic Granulomatosis with Polyangiitis in the U.S. Initiating Mepolizumab
  

  Abstract Poster Presenter: Arijita Deb, PhD – GlaxoSmithKline
• 1:00 PM – 3:00 PM Eastern Time

  Should Arthrocentesis Be Attempted in the Symptomatic but Non-Effusive Knee?
  

  Abstract Poster Presenter: Rosemina Patel, MD – University of New Mexico School of Medicine
• 1:00 PM – 3:00 PM Eastern Time

  The Adult SAPHO and Chronic Nonbacterial Osteomyelitis Observational Study (The SAPHO-CNO Study) Supports Multidimensional Disease Symptomatology with High Levels of Pain and Fatigue, and Low Levels of Function
  

  Abstract Poster Presenter: Aleksander Lenert, MD, MS, FRCPC – University of Iowa
• 1:00 PM – 3:00 PM Eastern Time

  Advantages of Alternate-Day Glucocorticoid Treatment Strategy for IgG4-Related Disease: A Preliminary Retrospective Study ID: 1287015
  

  Abstract Poster Presenter: Sho Fukui, MD, MPH – Kyorin University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Effectiveness of Golimumab in the Treatment of Patients with Active Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis Who Failed Initial TNFα Therapy: A Pooled Analysis of European Prospective Observational Studies (the GO BEYOND Program)
  

  Abstract Poster Presenter: Marinella Govoni, PhD – MSD
• 1:00 PM – 3:00 PM Eastern Time

  Three Chinese Pedigrees of A20 Haploinsufficiency
  

  Abstract Poster Presenter: Min Shen – Chinese Academy of Medical Sciences & Peking Union Medical College
• 1:00 PM – 3:00 PM Eastern Time

  Racial Differences in Bone Health of Sarcoidosis Patients: A Retrospective Study
  

  Abstract Poster Presenter: Emily Peninger, MD – Jefrey Lieberman MD
• 1:00 PM – 3:00 PM Eastern Time

  Pleuroparenchymal Fibroelastosis: A Special Clinical Situation in Patients with Interstitial Lung Disease Associated with Connective Tissue Diseases. Descriptive Study from a Referral Centre
  

  Abstract Poster Presenter: Belen Atienza-Mateo, MD, PhD РHospital Universitario Marqu̩s de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Retention Rate of Targeted Therapies in Erdheim-Chester Disease
  

  Abstract Poster Presenter: Corrado Campochiaro, MD – IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University
• 1:00 PM – 3:00 PM Eastern Time

  Combination Treatment with Baricitinib and Pulse Steroids in Severe COVID19: A
  

  Abstract Poster Presenter: Francesco Ferro, MD – Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana
• 1:00 PM – 3:00 PM Eastern Time

  Janus Kinase Inhibitors in Severe and Refractory Inflammatory Ocular Pathology. Cases Reports and Literature Review
  

  Abstract Poster Presenter: Lara Sanchez-Bilbao, MD – Hospital Universitario Marques de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Sarcoidosis Incidence After mTOR Inhibitor Treatment
  

  Abstract Poster Presenter: Matthew Baker, MD, MS – Stanford University
• 1:00 PM – 3:00 PM Eastern Time

  Polyarticular Arthritis and Osteolysis Caused by Mutations in the ASAH1 Gene: Farber Disease Clinical Presentations in the First-ever Natural History Study
  

  Abstract Poster Presenter: Nils Confer, PhD, MBA – Aceragen
• 1:00 PM – 3:00 PM Eastern Time

  Patients with Familial Mediterranean Fever (FMF) Under Canakinumab Treatment - Long-term Efficacy and Safety Interim Data of the RELIANCE Registry
  

  Abstract Poster Presenter: Jorg Henes, MD – University Hospital Tuebingen
• 1:00 PM – 3:00 PM Eastern Time

  A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira®)
  

  Abstract Poster Presenter: Steven Feldman, MD, PhD – Wake Forest University School of Medicine
• 1:00 PM – 3:00 PM Eastern Time

  Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs): Data from INBUILD-ON
  

  Abstract Poster Presenter: Eric L. Matteson, MD, MPH – Mayo Clinic College of Medicine and Science
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  A Systemic Autoinflammatory Syndrome Caused by NEMO Exon 5 Skipping
  

  Abstract Poster Presenter: Bin Lin, PhD – NIH
• 1:00 PM – 3:00 PM Eastern Time

  National Multicenter Study of 80 Patients with Refractory Uveitis Due to Immune-Mediated Inflammatory Diseases Treated with Certolizumab Pegol
  

  Abstract Poster Presenter: Jose Luis Martin-Varillas, MD – Hospital Laredo
• 1:00 PM – 3:00 PM Eastern Time

  The Association of Hypocomplementemia with Organ Involvement and Serum IgG4 in IgG4-related Disease
  

  Abstract Poster Presenter: Guy Katz, MD – Massachusetts General Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Vaccination Immune Response Against Sars-Cov-2 in Patients with Autoimmune Rheumatic Diseases
  

  Abstract Poster Presenter: Paula Corbalan, MD – Hospital Ángel C. Padilla
• 1:00 PM – 3:00 PM Eastern Time

  Intravenous versus Subcutaneous Tocilizumab in a Series of 471 Patients with Giant Cell Arteritis
  

  Abstract Poster Presenter: Lara Sanchez-Bilbao, MD – Hospital Universitario Marques de Valdecilla
• 1:00 PM – 3:00 PM Eastern Time

  Rituximab in IgG4-Related Diseae: An Open-Label Non-Randomized Observational Study
  

  Abstract Poster Presenter: Jens Vikse, MD – Stavanger University Hospital
• 1:00 PM – 3:00 PM Eastern Time

  Dysferlin Associated Autoinflammatory Disease Causing Systemic Inflammation and Sterile Lung Abcesses Through Impaired Efferocytosis
  

  Abstract Poster Presenter: Farzana Bhuyan, PhD – National Institutes of Health